Can Indian regulator “fix” drug combos?

Come September 30, a new deadline that the Indian drugs regulator, Drugs Controller General of India, has set for state food and drug administrations to produce safety and efficacy data on scores of marketed fixed dose combinations - two or more molecules combined in specific ratios - from manufacturers, will lapse. This is the latest effort by the DCGI to weed out … Continue reading Can Indian regulator “fix” drug combos?